| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cellectar Biosciences, Inc. | Senior Vice President, Medical | Common Stock | 55,038 | $15,411 | $0.2800 | 08 Dec 2023 | Direct |
| Cellectar Biosciences, Inc. | Senior Vice President, Medical | Stock option (right to buy) | 260,000 | 14 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CLRB | Cellectar Biosciences, Inc. | 14 Jun 2024 | 1 | $0 | 4 | Senior Vice President, Medical | 18 Jun 2024, 17:03 |
| CLRB | Cellectar Biosciences, Inc. | 08 Dec 2023 | 1 | $0 | 4 | Senior Vice President, Medical | 12 Dec 2023, 20:05 |
| CLRB | Cellectar Biosciences, Inc. | 15 Feb 2023 | 1 | $0 | 4 | Senior Vice President, Medical | 16 Mar 2023, 18:02 |
| CLRB | Cellectar Biosciences, Inc. | 15 Feb 2023 | 0 | $0 | 3 | Senior Vice President, Medical | 16 Mar 2023, 18:01 |